Reporting owner · Q3 2026 · CIK 1468308

Andrade Robert: insider trades.

Andrade Robert reported 5 non-derivative transactions on 4 SEC ownership filings in Q3 2026: 0 open-market purchases and 1 sale ($884K), across 1 company.

Transactions
5
Purchases (P)
0
Sales (S)
1
Companies
1
Name as filed
Andrade Robert

Companies

CompanyRelationshipTransactions
Fennec Pharmaceuticals Inc. (FENC)Officer · CHIEF FINANCIAL OFFICER5

Transactions

5 non-derivative rows. Shares and prices as filed.
DateCompanyCodeSharesPriceOwned afterFiling
2026-08-31Fennec Pharmaceuticals Inc.A1,703$0241,306Form 4
2026-08-28Fennec Pharmaceuticals Inc.M21,928$5.1239,603Form 4
2026-08-27Fennec Pharmaceuticals Inc.S75,000$11.78217,675Form 4
2026-07-31Fennec Pharmaceuticals Inc.A1,703$0292,675Form 4
2026-06-30Fennec Pharmaceuticals Inc.A1,703$0290,972Form 4

Questions

What stock did Andrade Robert buy or sell?

Andrade Robert reported 5 non-derivative transactions on 4 SEC ownership filings in Q3 2026: 0 open-market purchases and 1 sale ($884K), across 1 company.

Is Andrade Robert the same person as other filers with this name?

This page covers SEC CIK 1468308 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.

Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.

Plain-text version for agents and LLMs: /insiders/andrade-robert-1468308.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.